Увійти

Готові списки джерел за темами / Smart Inhalers / Статті в журналах

Щоб переглянути інші типи публікацій з цієї теми, перейдіть за посиланням: Smart Inhalers.

Статті в журналах з теми "Smart Inhalers"

Автор: Grafiati

Опубліковано: 7 червня 2025

Оновлено: 2 серпня 2025

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями

Оберіть тип джерела:

Ознайомтеся з топ-50 статей у журналах для дослідження на тему "Smart Inhalers".

Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.

Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.

Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.

1

Zalak, Prajapati* Sifa Meman Mona Gupta Nisha Patel Sandhya Bodhe C. Patel. "A Review on Smart Inhalers: A Smart Approach to COPD and Asthma." International Journal of Pharmaceutical Sciences 3, no. 5 (2025): 982–92. https://doi.org/10.5281/zenodo.15351341.

Повний текст джерела

Анотація:

The development of smart inhalers represents a significant advancement in the management of asthma and chronic obstructive pulmonary disease (COPD). These devices integrate digital technology with traditional inhalation systems to monitor medication usage, track adherence, and provide real-time feedback to patients and healthcare providers. Smart inhalers are equipped with sensors that collect data on inhalation patterns, dosage, and environmental factors, enabling personalized treatment strategies and early detection of exacerbations. Digital devices that record inspiratory flows with inhaler

Стилі APA, Harvard, Vancouver, ISO та ін.

2

Alkhodair, Rawan Fahad, Abdullah Nasser Almusfir, Faisal Mohammed Alosaimi, et al. "Smart inhalers: Transforming asthma management and the pharmacist's involvement in patient education." International journal of health sciences 7, S1 (2023): 3598–613. http://dx.doi.org/10.53730/ijhs.v7ns1.15260.

Повний текст джерела

Анотація:

Background: Asthma remains a global healthcare challenge despite advancements in classification, diagnosis, and inhalation therapy. A significant proportion of patients continue to experience uncontrolled asthma, which is linked to factors such as non-adherence to treatment and improper inhaler technique. Aim: This article aims to explore the potential of smart inhalers in transforming asthma management and to highlight the critical role of pharmacists in patient education. Methods: A comprehensive review of literature was conducted, focusing on the prevalence of uncontrolled asthma, the impac

Стилі APA, Harvard, Vancouver, ISO та ін.

3

Kavitha, M. "Smart Inhalers." Journal of Nursing Trendz 10, no. 3 (2019): 34. http://dx.doi.org/10.5958/2249-3190.2019.00029.4.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

4

Hamzavi, Mohammad. "Combination Therapy with Budesonide and Formoterol in Single Inhaler of Asthma." Clinical Medicine Insights: Therapeutics 2 (January 2010): 1179559X1000200. http://dx.doi.org/10.1177/1179559x1000200002.

Повний текст джерела

Анотація:

Inhaled corticosteroids are the mainstay of asthma therapy, but there is now compelling evidence that addition of a long-acting inhaled β2-agonist, such as formoterol, gives better control in terms of reduced symptoms, improved lung function and reduced exacerbations in patients with mild to severe persistent asthma than increasing the dose of corticosteroids in patients not fully in control by low dose. This has led to development of fixed dose combination inhalers such as budesonide/formoterol. Budesonide/formoterol combination in a single inhaler represents a safe, effective and convenient

Стилі APA, Harvard, Vancouver, ISO та ін.

5

Atharva, Patil Yamin Bisen Harshada Nikam. "Review On Smart Inhaler for Asthma Management with Integrated Dosing Technology." International Journal of Pharmaceutical Sciences 2, no. 11 (2024): 154–66. https://doi.org/10.5281/zenodo.14029848.

Повний текст джерела

Анотація:

Asthma management has traditionally relied on patient adherence to medication regimens and symptom tracking. Recent advancements in technology have led to the development of smart inhalers, which integrate dosing technology with digital health tools to enhance asthma care. This paper presents an overview of a smart inhaler designed to monitor medication use, track environmental triggers, and provide real-time feedback to patients and healthcare providers. The device utilizes Bluetooth connectivity to sync data with a mobile application, allowing users to record symptoms, medication adherence,

Стилі APA, Harvard, Vancouver, ISO та ін.

6

Owunyesiga, Chrispus. "Engineering Smart Inhalers for Asthma Management." Research Output Journal of Engineering and Scientific Research 4, no. 1 (2025): 23–28. https://doi.org/10.59298/rojesr/2025/4.1.2328.

Повний текст джерела

Анотація:

Asthma, a chronic respiratory condition affecting approximately 12% of the global population, is primarily managed using inhalers that deliver medication directly to the lungs. However, traditional inhalers face significant challenges related to patient adherence, correct usage, and accessibility. In recent years, smart inhalers, equipped with sensors and connectivity features, have emerged as a promising solution. These devices are designed to enhance medication adherence, provide real-time feedback, and monitor patient behavior through data analytics. This review examines the role of smart i

Стилі APA, Harvard, Vancouver, ISO та ін.

7

Dierick, Boudewijn H. J., Maria Achterbosch, Sandra Been-Buck, et al. "Can electronic monitoring with a digital smart spacer support personalised medication adherence and inhaler technique education in patients with asthma?: Protocol of the randomised controlled OUTERSPACE trial." BMJ Open 12, no. 6 (2022): e059929. http://dx.doi.org/10.1136/bmjopen-2021-059929.

Повний текст джерела

Анотація:

IntroductionMedication adherence and inhaler technique in patients with asthma remain suboptimal. A digital, smart spacer may support personalised adherence and inhaler technique education. The aim of this study is to assess the feasibility of undertaking a definitive randomised controlled trial of personalised, smart spacer data-driven education and explore clinical benefits.Methods and analysisWe present the design of the multicentre, randomised controlled OUtcomes following Tailored Education and Retraining: Studying Performance and AdherenCE feasibility trial of 2 months. Patients will be

Стилі APA, Harvard, Vancouver, ISO та ін.

8

Lawrie, Louisa, Stephen Turner, Seonaidh C. Cotton, Jessica Wood, and Heather M. Morgan. "A qualitative process evaluation within a clinical trial that used healthcare technologies for children with asthma–insights and implications." PLOS ONE 18, no. 1 (2023): e0280086. http://dx.doi.org/10.1371/journal.pone.0280086.

Повний текст джерела

Анотація:

Background Healthcare technologies are becoming more commonplace, however clinical and patient perspectives regarding the use of technology in the management of childhood asthma have yet to be investigated. Within a clinical trial of asthma management in children, we conducted a qualitative process evaluation that provided insights into the experiences and perspectives of healthcare staff and families on (i) the use of smart inhalers to monitor medication adherence and (ii) the use of algorithm generated treatment recommendations. Methods We interviewed trial staff (n = 15) and families (n = 6

Стилі APA, Harvard, Vancouver, ISO та ін.

9

Asaju, Babajide, Woosub Jubg, Almustapha A. Wakili,, Xavier Polymer, Lucas N. Potter, and Michaela Barnett. "Safeguarding Smart Inhaler Devices and Patient Privacy in Respiratory Health Monitoring." International Conference on Cyber Warfare and Security 20, no. 1 (2025): 18–27. https://doi.org/10.34190/iccws.20.1.3470.

Повний текст джерела

Анотація:

The rapid development of Internet of Things (IoT) technology has significantly impacted various market sectors. According to Li et al (2024), an estimated 75 billion devices will be on the market in 2025. The healthcare industry is a target to improve patient care and ease healthcare provider burdens. Chronic respiratory disease is likely to benefit from their inclusion, with 545 million people worldwide recorded to suffer in patients using these devices can track their dosage, while healthcare providers can improve medication administration and monitor respiratory health (Soriano et al, 2020)

Стилі APA, Harvard, Vancouver, ISO та ін.

10

Renaud, Yann, Philipp Suter, and Gael Grandmaison. "Patient Characteristics to Consider When Selecting an Inhaler for the Treatment of Chronic Obstructive Pulmonary Disease and Available Assessment Methods: A Narrative Review." Respiration 102, no. 6 (2023): 416–25. http://dx.doi.org/10.1159/000530277.

Повний текст джерела

Анотація:

Inhaler misuse is common among patients with chronic obstructive pulmonary disease and associated with poor disease control. Many patient characteristics are reported to impact inhaler use, but there are no studies in the literature on the best way to evaluate them. This narrative review aims to identify patient characteristics that influence the correct use of an inhaler and describe the tools available for their assessment. First, we searched four different databases to identify reviews describing patient characteristics reported to impact inhaler use. In a second step, ways to characterize

Стилі APA, Harvard, Vancouver, ISO та ін.

11

Mysovskikh, Ivan, Mathew Legg, and Serge Demidenko. "Flowrate Sensing and Measurement in Portable Smart Inhalers." Sensors 24, no. 21 (2024): 6848. http://dx.doi.org/10.3390/s24216848.

Повний текст джерела

Анотація:

This review discusses approaches and implementations of flowrate sensing and measurement in smart inhalers for effective respiratory disease management. It highlights the importance of compliance with proper inhaling techniques and consistent adherence for managing respiratory conditions. Methods and relevant commercial and prototype research-type devices for sensing and measuring inhalation flowrate in smart inhalers are studied and compared. The study argues that the utilisation of acoustic analysis and air-pressure sensing is a promising approach to detect and evaluate the inhaling action,

Стилі APA, Harvard, Vancouver, ISO та ін.

12

Häußermann, Sabine, Laura J. Arendsen, and John N. Pritchard. "Smart dry powder inhalers and intelligent adherence management." Advanced Drug Delivery Reviews 191 (December 2022): 114580. http://dx.doi.org/10.1016/j.addr.2022.114580.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

13

Khusial, Rishi Jayant, Jacob K. Sont, Omar S. Usmani, et al. "The Effect of Inhaled Beta-2 Agonists on Heart Rate in Patients With Asthma: Sensor-Based Observational Study." JMIR Cardio 8 (December 11, 2024): e56848. https://doi.org/10.2196/56848.

Повний текст джерела

Анотація:

Background Beta-2 agonists play an important role in the management of asthma. Inhaled long-acting beta-2 agonists (LABAs) and short-acting beta-2 agonists (SABAs) cause bronchodilation by stimulating adrenoceptors. These receptors are also present in cardiac cells and, as a side effect, could also be stimulated by inhaled beta-2 agonists. Objective This study aims to assess the effect of beta-2 agonists on heart rate (HR). Methods The data were retrieved from an observational study, the myAirCoach Quantification Campaign. Beta-2 agonist use was registered by self-reported monthly questionnair

Стилі APA, Harvard, Vancouver, ISO та ін.

14

Raikar, Amisha S., Pramod Kumar, Gokuldas (Vedant) S. Raikar, and Sandesh N. Somnache. "Advances and Challenges in IoT-Based Smart Drug Delivery Systems: A Comprehensive Review." Applied System Innovation 6, no. 4 (2023): 62. http://dx.doi.org/10.3390/asi6040062.

Повний текст джерела

Анотація:

In the current era of technology, the internet of things (IoT) plays a vital role in smart drug delivery systems. It is an emerging field that offers promising solutions for improving the efficacy, safety, and patient compliance of drug therapies. IoT-based drug delivery systems leverage advanced devices, sophisticated sensors, and smart tools to monitor and analyse the health matrices of the patient in real-time, allowing for personalised and targeted drug delivery. This technology is implemented through various types of devices, including wearable and implantable devices such as infusion pum

Стилі APA, Harvard, Vancouver, ISO та ін.

15

Mosnaim, Giselle, Michelle Carrasquel, Tatum Ewing, Alba Berty, and Madeline Snedden. "Remote monitoring in asthma: a systematic review." European Respiratory Review 34, no. 175 (2025): 240143. https://doi.org/10.1183/16000617.0143-2024.

Повний текст джерела

Анотація:

BackgroundPoor adherence to maintenance inhalers and incorrect maintenance and reliever inhaler technique are associated with poor asthma outcomes. Remote therapeutic monitoring and remote patient monitoring support asthma guideline recommendations to regularly review adherence and inhaler technique, with the ultimate goal to improve asthma outcomes.ObjectiveThis work systematically reviewed all clinical trials testing remote monitoring interventions on asthma outcomes.MethodsA systematic search of PubMed, SCOPUS, Ovid, CINAHL and reference review databases was conducted from 1 January 2000 to

Стилі APA, Harvard, Vancouver, ISO та ін.

16

Chan, Amy Hai Yan, Braden Te Ao, Christina Baggott, et al. "DIGIPREDICT: physiological, behavioural and environmental predictors of asthma attacks—a prospective observational study using digital markers and artificial intelligence—study protocol." BMJ Open Respiratory Research 11, no. 1 (2024): e002275. http://dx.doi.org/10.1136/bmjresp-2023-002275.

Повний текст джерела

Анотація:

IntroductionAsthma attacks are a leading cause of morbidity and mortality but are preventable in most if detected and treated promptly. However, the changes that occur physiologically and behaviourally in the days and weeks preceding an attack are not always recognised, highlighting a potential role for technology. The aim of this study ‘DIGIPREDICT’ is to identify early digital markers of asthma attacks using sensors embedded in smart devices including watches and inhalers, and leverage health and environmental datasets and artificial intelligence, to develop a risk prediction model to provid

Стилі APA, Harvard, Vancouver, ISO та ін.

17

Wallace, Gail, Linda Hopkinson, Suzanne Crockett, and Andrea Allanach. "Managing the transition to CFC-free inhalers: case studies from the SMART nurse project." Primary Care Respiratory Journal 11, no. 2 (2002): 47–51. http://dx.doi.org/10.1038/pcrj.2002.17.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

18

Kadam, Vaishnavi, Soham Raorane, Chirag Dodia, and Apurva Shardul. "Fog-Enabled Efficient Asthma Monitoring System." International Journal for Research in Applied Science and Engineering Technology 11, no. 5 (2023): 75–80. http://dx.doi.org/10.22214/ijraset.2023.51407.

Повний текст джерела

Анотація:

Abstract: For monitoring patients at risk for chronic diseases, wireless and wearable sensors are now widely used in the healthcare sector. This guarantees that patients adhere to their treatment regimens and safeguards them from unexpected attacks. Numerous sensors have produced a vast amount of data. In this paper, we propose to use fog computing to support the monitoring of asthma patients using IoT-enabled devices such as smart inhalers to monitor the rate and environmental factors surrounding asthma attacks, ensuring that data is collected and processed effectively. The main challenge wou

Стилі APA, Harvard, Vancouver, ISO та ін.

19

Son, Junbo, Patricia Flatley Brennan, and Shiyu Zhou. "A Data Analytics Framework for Smart Asthma Management Based on Remote Health Information Systems with Bluetooth-Enabled Personal Inhalers." MIS Quarterly 44, no. 1 (2020): 285–303. http://dx.doi.org/10.25300/misq/2020/15092.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

20

Yan, Wudan. "Toward Better Management for Asthma: From Smart Inhalers to Injections to Wearables, Researchers Are Finding New Ways to Improve Asthma Treatment." IEEE Pulse 9, no. 1 (2018): 28–33. http://dx.doi.org/10.1109/mpul.2017.2772398.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

21

Algfari, Sultan Mohammed, Abeer Saleh Alghamdi, Eman Ibrahim Alshaikh Ali, et al. "Real-time health monitoring using IoT devices for patients with chronic conditions." International journal of health sciences 4, S1 (2020): 214–28. http://dx.doi.org/10.53730/ijhs.v4ns1.15149.

Повний текст джерела

Анотація:

Background: The healthcare sector is experiencing a transformative shift due to advancements in technology, particularly with the Internet of Things (IoT). IoT integration in healthcare is poised to revolutionize patient monitoring and management, particularly for individuals with chronic conditions. The Grand View Research Inc. analysis projected a significant increase in IoT penetration in healthcare, with a market value of approximately $409.9 billion by 2022. Aim: This article aims to explore the applications, benefits, and future potential of IoT devices in real-time health monitoring for

Стилі APA, Harvard, Vancouver, ISO та ін.

22

Harve, Akbar Fathoni. "The Analysis Study of Comparison of Effectiveness and Safety of Inhalers in Mild-to Moderate Asthma in Adults: A Comprehensive Systematic Review." Indonesian Journal of General Medicine 4, no. 1 (2024): 1–20. http://dx.doi.org/10.70070/d1wkvf29.

Повний текст джерела

Анотація:

Background: Asthma, a prevalent and potentially debilitating chronic disease, is traditionally managed using reliever medications such as short-acting β2-agonists (SABA) or low-dose inhaled corticosteroids (ICS). Recent evidence, however, indicates that a combination of as-needed ICS and a rapid-acting long-acting β2-agonist (LABA) provides superior outcomes compared to SABA alone. Furthermore, this combination therapy is at least as effective as regular ICS in mitigating the risk of exacerbations. This emerging evidence highlights a significant shift in treatment strategies for mild asthma, u

Стилі APA, Harvard, Vancouver, ISO та ін.

23

Kleinstreuer, C., and Z. Zhang. "Targeted Drug Aeroso Deposition Analysis for a Four-Generation Lung Airway Model With Hemispherical Tumors." Journal of Biomechanical Engineering 125, no. 2 (2003): 197–206. http://dx.doi.org/10.1115/1.1543548.

Повний текст джерела

Анотація:

One important research area of broad interest is the development of highly efficient drug delivery systems for desired site deposition and uptake. For example, controlled drug aerosol release and targeting to specific regions of the lung is a novel way to combat lung diseases, diabetes, virus infections, cancers, etc. Determination of feasible air-particle streams is a prerequisite for the development of such delivery devices, say, smart inhalers. The concept of “controlled particle release and targeting” is introduced and results are discussed for a representative model of bronchial lung airw

Стилі APA, Harvard, Vancouver, ISO та ін.

24

Ramamurthi, Divya, Cindy Chau, and Robert K. Jackler. "JUUL and other stealth vaporisers: hiding the habit from parents and teachers." Tobacco Control 28, no. 6 (2018): 610–16. http://dx.doi.org/10.1136/tobaccocontrol-2018-054455.

Повний текст джерела

Анотація:

BackgroundSome consumers wish to use vapour devices discreetly so that family members, teachers and coworkers do not recognise their use of nicotine ortetrahydrocannabinol (THC) laden vapour.MethodsStealthy vapour devices, as well as low-odour and low-vapour e-juices, were identified via a comprehensive online search between March and June 2018.ResultsAs evidence of their popularity, a search for ‘stealth vaping’ on YouTube found 18 200 videos. A variety of cleverly designed vapour devices disguised as USB sticks, pens, remote controls, car fobs, smart phones, sweatshirt drawstrings and even a

Стилі APA, Harvard, Vancouver, ISO та ін.

25

Jansen, Evalyne M., Susanne J. van de Hei, Boudewijn J. H. Dierick, Huib A. M. Kerstjens, Janwillem W. H. Kocks, and Job F. M. van Boven. "Global burden of medication non-adherence in chronic obstructive pulmonary disease (COPD) and asthma: a narrative review of the clinical and economic case for smart inhalers." Journal of Thoracic Disease 13, no. 6 (2021): 3846–64. http://dx.doi.org/10.21037/jtd-20-2360.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

26

Mai Noor Asiah Bt Tan Zalilah and Putri Irda Ab Rahman. "Design and Development Smart Inhaler System." J-Innovation 14, no. 1 (2025): 1–9. https://doi.org/10.55600/jipa.v14i1.270.

Повний текст джерела

Анотація:

The prevalence of respiratory diseases, such as asthma and Chronic Obstructive Pulmonary Disease (COPD), continues to increase worldwide, posing significant challenges for patients and healthcare systems. Monitoring remaining doses and inhaler dose notifications are becoming increasingly scarce, becoming a major concern for asthma patients. Therefore, the Smart Inhaler is designed to provide a real-time shrinking dose counter display and notifications via devices for refilling inhaler doses. This Smart Inhaler consists of a 3.7V power supply and Force Resistive Sensor used as input, display on

Стилі APA, Harvard, Vancouver, ISO та ін.

27

Rosière, Rémi, Thierry Berghmans, Paul De Vuyst, Karim Amighi, and Nathalie Wauthoz. "The Position of Inhaled Chemotherapy in the Care of Patients with Lung Tumors: Clinical Feasibility and Indications According to Recent Pharmaceutical Progresses." Cancers 11, no. 3 (2019): 329. http://dx.doi.org/10.3390/cancers11030329.

Повний текст джерела

Анотація:

Despite new treatment modalities, including targeted therapies and checkpoint inhibitors, cytotoxic chemotherapy remains central in the care of patients with lung tumors. Use of the pulmonary route to deliver chemotherapy has been proved to be feasible and safe in phase I, Ib/IIa and II trials for lung tumors, with the administration of drug doses to the lungs without prior distribution in the organism. The severe systemic toxicities commonly observed with conventional systemic chemotherapy are consequently reduced. However, development has failed in phase II at best. This review first focuses

Стилі APA, Harvard, Vancouver, ISO та ін.

28

Северинов, М. В., та М. А. Сергеева. "ВОЗМОЖНОСТИ ИСПОЛЬЗОВАНИЯ МИКРОКОНТРОЛЛЕРА STM32 ПРИ РАЗРАБОТКЕ МЕДИЦИНСКОЙ АППАРАТУРЫ". СИСТЕМНЫЙ АНАЛИЗ И УПРАВЛЕНИЕ В БИОМЕДИЦИНСКИХ СИСТЕМАХ 24, № 1 (2025): 122–25. https://doi.org/10.36622/1682-6523.2025.24.1.016.

Повний текст джерела

Анотація:

Современная медицина активно использует передовые технологии для улучшения диагностики, лечения и мониторинга состояния пациентов. Микроконтроллеры играют ключевую роль в этих процессах, обеспечивая высокую производительность и надежность медицинской аппаратуры. Среди множества микроконтроллеров, серия STM32 от компании STMicroelectronics выделяется благодаря своим уникальным характеристикам и широкому спектру применения. В этой статье мы подробно рассмотрим роль и ценность использования микроконтроллеров STM32 в медицинской аппаратуре, а также приведем примеры их применения. Более подробно в

Стилі APA, Harvard, Vancouver, ISO та ін.

29

A, YOKESH. "IoT-Enabled Smart Inhaler with GSM and Cloud-Based Health Monitoring System." INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH IN ENGINEERING AND MANAGEMENT 09, no. 05 (2025): 1–9. https://doi.org/10.55041/ijsrem47572.

Повний текст джерела

Анотація:

Abstract- Asthma is a chronic respiratory condition that affects millions of individuals worldwide and often leads to serious health complications due to missed medication and exposure to environmental triggers. To address this issue, this paper presents the design and development of an IoT-based Smart Inhaler System aimed at improving medication adherence, monitoring environmental conditions, and enabling real-time alerts during critical situations. The system comprises a smart inhaler unit embedded with a usage detection sensor and a wearable smart band equipped with temperature, humidity, a

Стилі APA, Harvard, Vancouver, ISO та ін.

30

Tsang, Kevin Cheuk Him, Hilary Pinnock, Andrew M. Wilson, Dario Salvi, and Syed Ahmar Shah. "Predicting asthma attacks using connected mobile devices and machine learning: the AAMOS-00 observational study protocol." BMJ Open 12, no. 10 (2022): e064166. http://dx.doi.org/10.1136/bmjopen-2022-064166.

Повний текст джерела

Анотація:

IntroductionSupported self-management empowering people with asthma to detect early deterioration and take timely action reduces the risk of asthma attacks. Smartphones and smart monitoring devices coupled with machine learning could enhance self-management by predicting asthma attacks and providing tailored feedback.We aim to develop and assess the feasibility of an asthma attack predictor system based on data collected from a range of smart devices.Methods and analysisA two-phase, 7-month observational study to collect data about asthma status using three smart monitoring devices, and daily

Стилі APA, Harvard, Vancouver, ISO та ін.

31

van de Hei, Susanne J., Charlotte C. Poot, Liselot N. van den Berg, et al. "Effectiveness, usability and acceptability of a smart inhaler programme in patients with asthma: protocol of the multicentre, pragmatic, open-label, cluster randomised controlled ACCEPTANCE trial." BMJ Open Respiratory Research 9, no. 1 (2022): e001400. http://dx.doi.org/10.1136/bmjresp-2022-001400.

Повний текст джерела

Анотація:

IntroductionSuboptimal asthma control is associated with incorrect inhaler use and poor medication adherence, which could lead to unfavourable clinical and economic outcomes. Smart inhaler programmes using electronic monitoring devices (EMDs) could support self-management and increase medication adherence and asthma control. However, evidence on long-term benefits and acceptability is scarce. This study aims to investigate the effectiveness of a smart inhaler asthma self-management programme on medication adherence and clinical outcomes in adults with uncontrolled asthma, to evaluate its accep

Стилі APA, Harvard, Vancouver, ISO та ін.

32

Rizadi Sasmita Darwis, Rizadi Sasmita Darwis, and Widi Kurniawan. "Rancang Bangun Smart Air Purifier." Jurnal Elektro dan Mesin Terapan (ELEMENTER), Vol. 7 No. 2 (2021) (November 30, 2021): 66–73. http://dx.doi.org/10.35143/elementer.v7i2.5170.

Повний текст джерела

Анотація:

The quality of the inhaled air affects the immune system and human health. If the air that is inhaled is dirty, it can interfere with daily human activities and one way to prevent it is to need a device that can identify and clean dirty air so that the need for clean air can be met and daily human activities will run smoothly. So in this final project, the author designed a Smart Air Purifier device to overcome the air contaminated by PM2.5 and PM10. The average error percentage value of the PM10 GP2Y1010AU0F sensor reading is 12.80%. This Smart Airpurifier device can perform purification in a

Стилі APA, Harvard, Vancouver, ISO та ін.

33

Zhang, Zhiguo, and Maoning Wei. "Development of a Smart Metered-Dose Inhaler for Asthma Based on Computational Fluid Dynamics." Symmetry 15, no. 9 (2023): 1712. http://dx.doi.org/10.3390/sym15091712.

Повний текст джерела

Анотація:

Asthma is a common respiratory disease with symptoms such as repeated wheezing, shortness of breath, and coughing. However, currently, asthma cannot be cured but only controlled or relieved using medication. The metered-dose inhaler (MDI) is known to lead to high deposition fractions of drug particles in the mouth and throat, resulting in inadequate drug efficacy. Therefore, herein, the factors influencing the deposition fraction of asthma drugs in the mouth and throat regions were explored by computational fluid dynamics and a smart MDI for asthma was designed. The smart MDI was designed base

Стилі APA, Harvard, Vancouver, ISO та ін.

34

Aalbers, René. "Single inhaler as maintenance and reliever therapy—is it SMART?" Lancet Respiratory Medicine 1, no. 1 (2013): 2–3. http://dx.doi.org/10.1016/s2213-2600(13)70020-1.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

35

Mandal, Santi M., and Souvik Panda. "Inhaler with electrostatic sterilizer and use of cationic amphiphilic peptides may accelerate recovery from COVID-19." BioTechniques 69, no. 3 (2020): 206–10. http://dx.doi.org/10.2144/btn-2020-0042.

Повний текст джерела

Анотація:

We explore the design of a smart inhaler with electrostatic sterilizer and propose the utilization of cationic amphiphilic peptides, independently or in conjunction with a bronchodilator, for COVID-19 patients to quickly improve wellbeing while maintaining a strategic distance to protect healthcare personnel from virus-containing aerosol or droplets during the process of inhalation.

Стилі APA, Harvard, Vancouver, ISO та ін.

36

Shin, Youn Ho, Seung Won Lee, and Dong Keon Yon. "Single Inhaler as Maintenance and Reliever Therapy (SMART) in Childhood Asthma in 2021: The Paradigm Shift in the Inhaled Corticosteroids Reliever Therapy Era." Journal of Allergy and Clinical Immunology: In Practice 9, no. 10 (2021): 3819–20. http://dx.doi.org/10.1016/j.jaip.2021.07.009.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

37

Burgess, Scott W., Suzanne S. I. Wilson, David M. Cooper, Peter D. Sly, and Sunalene G. Devadason. "In vitro evaluation of an asthma dosing device: The smart-inhaler." Respiratory Medicine 100, no. 5 (2006): 841–45. http://dx.doi.org/10.1016/j.rmed.2005.09.004.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

38

Qin, Yu, Jing Wang, Jingmin Qin, et al. "Correlation Meta-Analysis of the Efficacy of Inhaled Corticosteroids in Children with Asthma Based on Smart Medical Health." Journal of Healthcare Engineering 2022 (April 13, 2022): 1–12. http://dx.doi.org/10.1155/2022/6220774.

Повний текст джерела

Анотація:

Children are the reserve force for national construction, and children’s health is now being paid more and more attention. In today’s childhood asthma treatment, many are based on the treatment of common cough, and there is no strict division with asthma. Importantly, the efficacy of inhaled corticosteroids in the treatment of childhood asthma has been extensively studied in the medical community. However, there is no clear explanation for its specific efficacy and role. Research on childhood asthma has always been a key topic in medicine. This article aims to conduct a meta-analysis of the co

Стилі APA, Harvard, Vancouver, ISO та ін.

39

Greene, Garrett, and Richard W. Costello. "Personalizing medicine - could the smart inhaler revolutionize treatment for COPD and asthma patients?" Expert Opinion on Drug Delivery 16, no. 7 (2019): 675–77. http://dx.doi.org/10.1080/17425247.2019.1628017.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

40

Rogliani, Paola, Beatrice Ludovica Ritondo, Josuel Ora, Mario Cazzola, and Luigino Calzetta. "SMART and as-needed therapies in mild-to-severe asthma: a network meta-analysis." European Respiratory Journal 56, no. 3 (2020): 2000625. http://dx.doi.org/10.1183/13993003.00625-2020.

Повний текст джерела

Анотація:

To date, there are no network meta-analyses comparing the impact of as-needed treatments in asthma, including the single maintenance and reliever therapy (known as “SMART” or “MART”; for simplicity, SMART will be used hereafter) and the use of inhaled corticosteroid (ICS)/long-acting β2-agonist (LABA) combination exclusively on an as-needed basis. Therefore, we performed a systematic review and network meta-analysis concerning the efficacy and safety of SMART and as-needed therapies in asthma. Data from 32 096 asthmatic patients were extracted from 21 studies, lasting from 6 to 12 months. In a

Стилі APA, Harvard, Vancouver, ISO та ін.

41

Knyazheskaya, N. P. "Budesonide / formoterol as an inhaler for basic therapy and relief of asthma symptoms (SMART strategy)." PULMONOLOGIYA, no. 6 (December 28, 2007): 87–92. http://dx.doi.org/10.18093/0869-0189-2007-0-6-87-92.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

42

Thomas, Mike, and Ian Pavord. "Single inhaler maintenance and reliever therapy (SMART) in general practice asthma management: where are we?" Primary Care Respiratory Journal 21, no. 1 (2012): 8–10. http://dx.doi.org/10.4104/pcrj.2012.00022.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

43

Furst, Stephen J., and Stefan Seelecke. "Fabrication and characterization of a dual-joint smart inhaler nozzle actuated by embedded SMA wires." Smart Materials and Structures 23, no. 3 (2014): 035008. http://dx.doi.org/10.1088/0964-1726/23/3/035008.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

44

Rumi, Gabriele, G. Walter Canonica, Juliet M. Foster, et al. "Digital Coaching Using Smart Inhaler Technology to Improve Asthma Management in Patients With Asthma in Italy: Community-Based Study." JMIR mHealth and uHealth 10, no. 11 (2022): e25879. http://dx.doi.org/10.2196/25879.

Повний текст джерела

Анотація:

Background Reliance on short-acting β-2 agonists and nonadherence to maintenance medication are associated with poor clinical outcomes in asthma. Digital health solutions could support optimal medication use and therefore disease control in patients with asthma; however, their use in community settings has not been determined. Objective The primary objective of this study is to investigate community implementation of the Turbu+ program designed to support asthma self-management, including adherence to budesonide and formoterol (Symbicort) Turbuhaler, a combination inhaler for both maintenance

Стилі APA, Harvard, Vancouver, ISO та ін.

45

Son, Junbo, Patricia Flatley Brennan, and Shiyu Zhou. "Rescue inhaler usage prediction in smart asthma management systems using joint mixed effects logistic regression model." IIE Transactions 48, no. 4 (2015): 333–46. http://dx.doi.org/10.1080/0740817x.2015.1078014.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

46

Orchard, M., D. Alderson, and V. Buchanan. "PRS6 EARLY Economic Modelling of a SMART Inhaler Exploring Cost-Effectiveness in a Severe Asthma Setting." Value in Health 23 (December 2020): S717. http://dx.doi.org/10.1016/j.jval.2020.08.1886.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

47

Cleland, Jennifer, David Price, Jan-Paul Rosen, Martyn Partridge, John Haughney, and Elizabeth Stahl. "ABS29: The SMART plan: development of a symptom-based asthma action plan for single inhaler therapy." Primary Care Respiratory Journal 15, no. 3 (2006): 193. http://dx.doi.org/10.1016/j.pcrj.2006.04.129.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

48

Miller, B., M. Sears, and A. Liovas. "PAS3 ECONOMIC EVALUATION OF SYMBICORT® (BUDESONIDE/FORMOTEROL) SINGLE-INHALER MAINTENANCE AND RELIEVERTHERAPY (SMART) IN ASTHMA." Value in Health 9, no. 3 (2006): A100. http://dx.doi.org/10.1016/s1098-3015(10)64617-7.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

49

Chakravarthy, K. K. J., P. S. Brahmanandam, D. M. Potukuchi, G. Anil Kumar, and N. S. Subba Rao. "Simulations of silicon nanowire sensor and an integrated smart bio-nano sensor." International Journal of Dental Materials 04, no. 03 (2022): 58–61. http://dx.doi.org/10.37983/ijdm.2022.4302.

Повний текст джерела

Анотація:

Background:Simulation-based nano biosensors have been introduced in recent times that will provide a model for the researchers to verify various critical functions of them, which could effectively save time, money, and effort.Materials and Methods:In this study, we have performed simulations of a silicon nanowire (Si-NW) biosensor, and its various parameters were evaluated. This silicon sensor was designed using the BiosensorLab tool, a simulator from the nanohub website. This paper also presentedan Integrated Smart Bio-nano Sensor. The motivation behind this smart sensor was that an incident

Стилі APA, Harvard, Vancouver, ISO та ін.

50

Chamaon, Dumiana, Esther Sportel, Emma Elferink, and Job van der Palen. "Validation of an AI-Powered Smart Dry Powder Inhaler (RS01X) for Asthma and COPD in a Clinical Setting." International Journal of Chronic Obstructive Pulmonary Disease Volume 20 (March 2025): 811–19. https://doi.org/10.2147/copd.s490684.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Ми пропонуємо знижки на всі преміум-плани для авторів, чиї праці увійшли до тематичних добірок літератури. Зв'яжіться з нами, щоб отримати унікальний промокод!